Abstract Details
|
George Nomikos
PRESENTER |
No disclosure on file |
| Helen Colquhoun | Helen Colquhoun has received personal compensation for serving as an employee of Sage Therapeutics. Helen Colquhoun has stock in Sage Therapeutics. Helen Colquhoun has received intellectual property interests from a discovery or technology relating to health care. |
| No disclosure on file | |
| Shane Raines | Shane Raines has received personal compensation for serving as an employee of 2b Analytics, LLC. |
| James Doherty, PhD (Sage Therapeutics) | Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics. |
| Ethan Hoffman | No disclosure on file |
| Abdul J. Sankoh, PhD | No disclosure on file |
| Steve Kanes, MD, PhD (Sage Therapeutics) | Dr. Kanes has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Kanes has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Verge Genomics. Dr. Kanes has received intellectual property interests from a discovery or technology relating to health care. |